A Multicenter Single-Blinded Controlled Trial Comparing Nasal Outcomes Using Saline Irrigation After Endonasal Pituitary Surgery-The Nose Trial
Journal of Neurological Surgery Part B: Skull Base · 01.03.2026 · 87 (S 01 S 01) · S1-S548
DOI: 10.1055/s-0046-1818684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.03.2026. Verfasst von Anthony M. Asher und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Although nasal saline irrigation is widely used with the intention of alleviating sinonasal symptoms after endoscopic pituitary surgery, no randomized trial has evaluated its efficacy.
Objective
To determine whether daily postoperative nasal irrigation improves patient-reported sinonasal quality of life.
Methods
In this multicenter, single-blind randomized controlled trial, adults undergoing endoscopic pituitary surgery were randomized 1:1 to nasal irrigation or to no irrigation. Exclusion criteria included chronic sinusitis, Cushing’s disease, craniopharyngioma, or planned naso-septal flap. Patients completed SNOT-22 and ASK-12 questionnaires preoperatively and at weeks 1, 2, 4, 8, and 12 postop. Lund–Kennedy nasal cavity scores (LKS) were recorded preoperatively and at weeks 1, 4, and 12 postop. The primary endpoint was the difference in SNOT-22 scores between groups at 4 weeks postop. Target enrollment was 140 total patients, but the study was terminated early due to funding constraints.
Results
Of 56 screened patients, 52 were randomized ( n = 27 irrigation; n = 25 control) and 44 were included in the final analysis (25 vs 19) ([ Fig. 1 ]). Pre-operative patient characteristics were comparable ( Table 1 ). At the primary endpoint, the difference in mean SNOT-22 total scores between groups did not reach statistical significance or minimum clinically important difference (MCID) of 7.5 (-7.3, p = 0.068). No significant or supra MCID between-group differences were observed in SNOT-22 or LKS raw or change scores at any time point ( Tables 2–4 ). ASK-12 raw and change score mean differences did meet MCID (>0.37) at several time points, however the results were not statistically significant.
Conclusion
Although this study did not find a statistically significant difference in sinonasal QOL and nasal cavity scores between patients who used saline irrigation and those who did not, the observed data allow for more refined power calculations for a larger trial. With α = 0.05 and power = 0.80, a future trial would require ~114 total patients to detect a significant difference in the primary QOL outcome. Fig. 1 CONSORT Flow Diagram. Fig. 2 Absolute SNOT-22 Score by Week. Publication History Article published online: 27 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Asher, A. M., Woodard, T. D., Kshettry, V. R., Evans, J. J., Little, A. S., Sindwani, R., & Santarelli, G. D. (2026). A Multicenter Single-Blinded Controlled Trial Comparing Nasal Outcomes Using Saline Irrigation After Endonasal Pituitary Surgery-The Nose Trial. Journal of Neurological Surgery Part B: Skull Base, 87(S 01 S 01), S1-S548. https://doi.org/10.1055/s-0046-1818684
Vancouver
Asher AM, Woodard TD, Kshettry VR, Evans JJ, Little AS, Sindwani R, et al. A Multicenter Single-Blinded Controlled Trial Comparing Nasal Outcomes Using Saline Irrigation After Endonasal Pituitary Surgery-The Nose Trial. Journal of Neurological Surgery Part B: Skull Base. 2026;87(S 01 S 01):S1-S548. doi:10.1055/s-0046-1818684
BibTeX
@article{Asher2026,
author = {Asher, Anthony M. and Woodard, Troy D. and Kshettry, Varun R. and Evans, James J. and Little, Andrew S. and Sindwani, Raj and Santarelli, Griffin D.},
title = {A Multicenter Single-Blinded Controlled Trial Comparing Nasal Outcomes Using Saline Irrigation After Endonasal Pituitary Surgery-The Nose Trial},
journal = {Journal of Neurological Surgery Part B: Skull Base},
year = {2026},
volume = {87},
number = {S 01 S 01},
pages = {S1--S548},
doi = {10.1055/s-0046-1818684}
}
EUVIMED